Nilutamide is a non-steroidal anti-androgen of the imidazolidinedione class, primarily utilized in the management of metastatic prostate cancer. By acting as an androgen receptor antagonist, the drug blocks… Read more









Nilutamide is a non-steroidal anti-androgen of the imidazolidinedione class, primarily utilized in the management of metastatic prostate cancer. By acting as an androgen receptor antagonist, the drug blocks the physiological effects of androgens and suppresses tumor progression in hormone-sensitive cancers. Laboratories and pharmaceutical researchers rely on high-quality reference standards of Nilutamide to perform rigorous analytical testing and quality control procedures. The availability of these materials, including pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds such as Nilutamide-d6, is essential for accurate impurity profiling. These labelled internal standards are particularly valuable in mass spectrometry and chromatographic assays, providing precise quantification during method validation and routine stability testing. By utilizing these certified reference materials, analytical chemists ensure compliance with regulatory standards and maintain consistency throughout the pharmaceutical development and manufacturing process.